⌘K
Loading ticker…
As of 2026-08-24, Cogent Biosciences, Inc. Common Stock (COGT) has a 3-month relative strength percentile of 69 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 64. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.9%, relative volume 0.67×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
COGT is held by 28 ETFs as of May 2026. Top owner: SCHA at 0.11% weight, $26M notional. Top 3 carry $60M.
Held by 64 ETFs · $933M across latest filings · largest weight 7.53% (LFSC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.11% | $26M | −0.03 pp |
| VTWO | 0.15% | $26M | −0.03 pp |
| VHTVanguard Health Care ETF | 0.05% | $9M | — |
| LFSC | 7.53% | $8M | −1.52 pp |
| CANC | 4.10% | $7M | +0.81 pp |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.26% |
| $4M |
| −0.06 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $3M | — |
| VFMO | 0.16% | $3M | −0.01 pp |
| DWAS | 0.64% | $3M | −0.45 pp |
| ONEQ | 0.01% | $1M | — |
Showing 10 of 28 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | COGT Jan avg: 6.52% median: 10.23% win: 75% σ: 24.02% n: 4 2022-04-12 → 2026-07-31 | COGT Feb avg: 8.73% median: -1.98% win: 50% σ: 34.84% n: 4 2022-04-12 → 2026-07-31 | COGT Mar avg: -10.96% median: -11.22% win: 0% σ: 9.92% n: 4 2022-04-12 → 2026-07-31 | COGT Apr avg: -9.99% median: -7.02% win: 0% σ: 10.32% n: 5 2022-04-12 → 2026-07-31 | COGT May avg: 1.25% median: 4.42% win: 60% σ: 18.94% n: 5 2022-04-12 → 2026-07-31 | COGT Jun avg: 28.89% median: 10.70% win: 100% σ: 39.19% n: 5 2022-04-12 → 2026-07-31 | COGT Jul avg: 20.83% median: 11.86% win: 100% σ: 22.80% n: 5 2022-04-12 → 2026-07-31 | COGT Aug avg: 15.59% median: 9.84% win: 75% σ: 23.53% n: 4 2022-04-12 → 2026-07-31 (current) | COGT Sep avg: -2.56% median: -4.48% win: 50% σ: 16.60% n: 4 2022-04-12 → 2026-07-31 | COGT Oct avg: -1.23% median: -1.06% win: 50% σ: 13.61% n: 4 2022-04-12 → 2026-07-31 | COGT Nov avg: 28.92% median: -6.92% win: 25% σ: 78.71% n: 4 2022-04-12 → 2026-07-31 | COGT Dec avg: -15.28% median: -14.83% win: 0% σ: 6.75% n: 4 2022-04-12 → 2026-07-31 |